Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Reckitt Benckiser (OP: RBGPF )

60.88 -2.30 (-3.65%)
Streaming Delayed Price Updated: 2:11 PM EDT, Apr 25, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Reckitt Benckiser

FDA Wants To Pull Popular OTC Decongestant Used For Common Cold Over Effectiveness Concerns
FDA proposes removing oral phenylephrine from OTC drugs for nasal congestion, citing ineffectiveness. Public comments open before a final order is issued. 
Via Benzinga
Exposures Product Safety
Consumer Giant Reckitt Seeks Help From Investment Banks To Evaluate Options For Homecare Brands, Baby Formula
Reckitt Benckiser is reportedly in early talks to sell its homecare division, featuring brands like Air Wick and Calgon, as part of a broader strategy to focus on consumer health and hygiene. The sale... 
Via Benzinga
Similac Baby Formula Maker Abbott And Reckitt Face Hundreds Of Baby Formula Lawsuits
Abbott faces trial over claims its baby formula causes necrotizing enterocolitis in preterm infants. This is the second trial among hundreds of similar lawsuits, impacting Abbott and Reckitt... 
Via Benzinga
Topics Lawsuit
Exposures Financial Legal
What's Going On With Abbott Laboratories Stock On Friday?
An Illinois jury orders Reckitt Benckiser's Mead Johnson to pay $60 million after a premature infant's tragic death linked to Enfamil baby formula. Mead Johnson found negligent for not warning about... 
Via Benzinga
Topics Lawsuit
Exposures Financial Legal
Durex Owner Reckitt Benckiser Taps Into China's Livestreaming Trend To Sell Condoms Online
Reckitt Benckiser Group is leveraging the popularity of livestream shopping in China to sell condoms, a move that could be challenging due to strict regulatory oversight. 
Via Benzinga
British Consumer Company Reckitt Benckiser's CEO Steps Down
Via Benzinga
FDA Panel Says Popular OTC Cold, Allergy Medicine Might Be Useless - Stocks To Watch
According to FDA panel experts who reviewed the latest research on the long-questioned phenylephrine, a drug ingredient used in several leading decongestants used by millions of Americans looking for... 
Via Benzinga
Exposures Product Safety
Is There Collusion in the Baby-Formula Industry?: FTC Scrutinizes State Contracts Bidding Process
Via Benzinga
Reckitt Sees US Baby Food Formula Crisis Persisting Till Spring: Report
Via Benzinga
Baby Formula Startup Seeks To Compete Abbott With 15% Market Share: Report
Via Benzinga
Reckitt Lifts Annual Forecast On Higher Prices, Baby Formula Shortage
Via Benzinga
More Companies Join Race To Ease US Baby Formula Supply Crunch
Danone SA (OTC: DANOY) has been doubling shipments to the U.S. of Neocate formula for infants allergic to cow's milk, while Enfamil maker Reckitt is also working to boost supplies amid a nationwide... 
Via Benzinga
Danone Scales Up Baby Formula Shipments To US To Combat Shortage: Reuters
Danone SA (OTC: DANOY) has stepped u 
Via Benzinga
Morning Brief: Top Financial Stories Dominating on Friday, April 29
CNBC Hertz Chief Sees Business Travel Recovery Choking Already Strained Used Car Supply Hertz Global Holdings, Inc (NASDAQ: HTZ) chief Stephen Scherr saw a recovery in business... 
Via Benzinga
Reckitt Benckiser Hikes Prices To Compensate For Falling Demand: FT
Reckitt Benckiser Group Plc (OTC: RBGLY) (OTC: RBGPF) has hiked prices across its product range to pass an increase in raw material costs onto customers, the Financial... 
Via Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.